Pylarify pet radiopharmaceutical
Ended Awarded Last action
- Contract number
- 36C24923N0130
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $410,652
Award facts
- Contract value 65% obligated
- $632,442.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Nashville, TN 37217, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$221,790 | |
| Original award | $632,443 |
About this award
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed price Blanket Purchase Agreement (BPA) call worth $632,442.60 to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. The contract is for the delivery of PYLARIFY, a radiopharmaceutical diagnostic agent used for positron emission tomography (PET) imaging of prostate cancer. This BPA, which is associated with the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allows various VA medical facilities across the Veterans Integrated Service Network (VISN) 9 to order PYLARIFY as needed. The contract does not have a set-aside designation. This award is part of the VA and Defense Health Agency's (DHA) procurement of radiopharmaceuticals to support their medical imaging programs for the detection and treatment of cancer and other diseases.
Quick answers
Who was awarded contract 36C24923N0130?
36C24923N0130 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on November 1, 2022.
How much is contract 36C24923N0130 worth?
The government has obligated $410,652 on 36C24923N0130. Its current value, with exercised options, is $632,443.
Is contract 36C24923N0130 an order under another contract?
Yes. 36C24923N0130 is a BPA call under 36F79719D0170-36C24923A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24923N0130 competed?
The extent of competition for 36C24923N0130 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award